Clinical trial
Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade…
NCT00213278 · The Hospital for Sick Children, Other · Completed
Key facts
| NCT number | NCT00213278 |
|---|---|
| Title | Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma |
| Official title | A Phase 2 Study of Vinblastine Sulphate Injection in Children With Recurrent or Refractory Low Grade Glioma |
| Lead sponsor | The Hospital for Sick Children, Other |
| Collaborators | Ontario Cancer Research Network |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Glioma |
| Intervention type | Drug |
| Interventions | vinblastine sulphate injection |
| Enrollment | 50 |
| Start date | Jan 1, 2002 |
| Primary completion | Sep 1, 2011 |
| Completion | Sep 1, 2012 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 20, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: